BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 32343003)

  • 1. Treating progressive disseminated histoplasmosis in people living with HIV.
    Murray M; Hine P
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD013594. PubMed ID: 32343003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment for HIV-associated cryptococcal meningitis.
    Tenforde MW; Shapiro AE; Rouse B; Jarvis JN; Li T; Eshun-Wilson I; Ford N
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD005647. PubMed ID: 30045416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early versus delayed antiretroviral treatment in HIV-positive people with cryptococcal meningitis.
    Eshun-Wilson I; Okwen MP; Richardson M; Bicanic T
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD009012. PubMed ID: 30039850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary antifungal prophylaxis for cryptococcal disease in HIV-positive people.
    Awotiwon AA; Johnson S; Rutherford GW; Meintjes G; Eshun-Wilson I
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD004773. PubMed ID: 30156270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amphotericin B deoxycholate versus liposomal amphotericin B: effects on kidney function.
    Botero Aguirre JP; Restrepo Hamid AM
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD010481. PubMed ID: 26595825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.
    Moen MD; Lyseng-Williamson KA; Scott LJ
    Drugs; 2009; 69(3):361-92. PubMed ID: 19275278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Voriconazole versus amphotericin B or fluconazole in cancer patients with neutropenia.
    Jørgensen KJ; Gøtzsche PC; Dalbøge CS; Johansen HK
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD004707. PubMed ID: 24563222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients.
    Cortegiani A; Russotto V; Maggiore A; Attanasio M; Naro AR; Raineri SM; Giarratano A
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD004920. PubMed ID: 26772902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ribavirin for treating Crimean Congo haemorrhagic fever.
    Johnson S; Henschke N; Maayan N; Mills I; Buckley BS; Kakourou A; Marshall R
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD012713. PubMed ID: 29869797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mefloquine for preventing malaria during travel to endemic areas.
    Tickell-Painter M; Maayan N; Saunders R; Pace C; Sinclair D
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD006491. PubMed ID: 29083100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children.
    Pienaar ED; Young T; Holmes H
    Cochrane Database Syst Rev; 2006 Jul; (3):CD003940. PubMed ID: 16856025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical azole treatments for otomycosis.
    Lee A; Tysome JR; Saeed SR
    Cochrane Database Syst Rev; 2021 May; 5(5):CD009289. PubMed ID: 34033120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shortened treatment regimens versus the standard regimen for drug-sensitive pulmonary tuberculosis.
    Grace AG; Mittal A; Jain S; Tripathy JP; Satyanarayana S; Tharyan P; Kirubakaran R
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD012918. PubMed ID: 31828771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotics for induction and maintenance of remission in Crohn's disease.
    Townsend CM; Parker CE; MacDonald JK; Nguyen TM; Jairath V; Feagan BG; Khanna R
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD012730. PubMed ID: 30731030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linezolid for drug-resistant pulmonary tuberculosis.
    Singh B; Cocker D; Ryan H; Sloan DJ
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD012836. PubMed ID: 30893466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primaquine alternative dosing schedules for preventing malaria relapse in people with Plasmodium vivax.
    Milligan R; Daher A; Villanueva G; Bergman H; Graves PM
    Cochrane Database Syst Rev; 2020 Aug; 8():CD012656. PubMed ID: 32816320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppressive treatment for proliferative lupus nephritis.
    Tunnicliffe DJ; Palmer SC; Henderson L; Masson P; Craig JC; Tong A; Singh-Grewal D; Flanc RS; Roberts MA; Webster AC; Strippoli GF
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD002922. PubMed ID: 29957821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the diagnostic test Xpert MTB/RIF on patient outcomes for tuberculosis.
    Haraka F; Kakolwa M; Schumacher SG; Nathavitharana RR; Denkinger CM; Gagneux S; Reither K; Ross A
    Cochrane Database Syst Rev; 2021 May; 5(5):CD012972. PubMed ID: 34097769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An updated systematic review of HIV-associated cryptococcal meningitis treatment strategies.
    Shapiro AE; Tenforde MW; Chiller TM; Ford N; Rajasingham R
    HIV Med; 2023 Apr; 24(4):507-512. PubMed ID: 36123803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal therapy in infants and children with proven, probable or suspected invasive fungal infections.
    Blyth CC; Hale K; Palasanthiran P; O'Brien T; Bennett MH
    Cochrane Database Syst Rev; 2010 Feb; 2010(2):CD006343. PubMed ID: 20166083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.